The document reviews first and second generation antipsychotics, how they work, their side effect profiles, and monitoring recommendations. It discusses the metabolic side effects of various antipsychotics like olanzapine and clozapine which can increase risks of diabetes, dyslipidemia, and weight gain. Monitoring of weight, glucose, lipids is recommended when prescribing antipsychotics to manage these metabolic risks.